THRUPORT SYSTEMS INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE: payments to doctors
Payments that named THRUPORT SYSTEMS INTRACLUDE INTRA-AORTIC OCCLUSION DEVICE as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $144K
- Providers
- 165
- Transactions
- 326
- Average per transaction
- $442
The per-transaction average — $442 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 165 providers the average total is $873, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Enablecv Inc. | $127,798 | 88.7% |
| Edwards Lifesciences | $16,323 | 11.3% |